A recent article in the New York Times about a study published last month in The Lancet, perhaps the most prestigious medical journal in the world, is no doubt creating a stir in the conventional-cardiology world. The headline was “Unbelievable”: Heart Stents Fail to Ease Chest Pain.

To the shock of many cardiologists who commented on the study, there was no difference in outcome of those who had the stent compared with those who had the dummy procedure.

As promised, I want to keep you updated about the reports we are getting from both my patients and practitioners who are using the strophanthus extract to treat heart disease. In these case studies below, some details get technical, such as the evaluation of the blood test results, but even if you don’t understand the details, the gist of the story comes through. I am immensely grateful for and heartened by these reports.

Sadly, the story of ouabain, the active ingredient in the plant strophanthus, is largely and somewhat mysteriously unknown. Few family doctors, internists and even cardiologists know of its effectiveness in treating and preventing heart disease and heart attacks, and it therefore remains unavailable to most heart patients.